Marinus is a new specialty pharmaceutical company dedicated to the development and commercialization of novel drugs to treat serious neurological, psychiatric, and pain disorders.
Financials
| Date | Type | Amount | Investors | Valuation |
|---|---|---|---|---|
| 10/01/05 | Series A | 29.5M | Unknown |
People
Kenneth Shaw (VP Research & Development)
Vincent Pieribone (Founding Discovery Officer)
Julia Tsai (Director of Drug Development)
Stephen Bloch (Chairman)
Anand Mehra (Board Member)
View more details about all 9 people at Marinus Pharmaceuticals